Webcast Central


AARC Webcasts are online educational events that take place right on your computer. AARC members can attend a live event and earn free CRCE© credit or watch a past program and take a quick test for credit.

Pre-registration is required for live events. Check your email for confirmation and further instructions after registering. CRCE Content Designation is provided to assist members seeking courses to satisfy the NBRC's Continuing Competency Requirements and the requirements of some states for specific content areas. If no content designation is provided, then the course is not designated as a specialty content course and should meet the requirements for continuing education of state boards.

The Role of the Respiratory Therapist in Cystic Fibrosis

Timezone Time
Eastern 2:00 PM
Central 1:00 PM
Mountain 12:00 PM
Pacific 11:00 AM
Universal 7:00 PM
Category Clinical Practice Speaker Dabney Eidson, BS, RRT, RRT-NPS Date May 29, 2018 1:00 PM

Cystic fibrosis is a non-curable genetic disease that affects mucus production and clearance in the lungs, pancreas, and other organs. Respiratory therapists interact with patients with cystic fibrosis throughout the stages of the disease: diagnosis in early childhood and disease progression through adulthood. It is important for respiratory therapists to not only understand the underlying physiology of the disease and how it is diagnosed but also what available treatment interventions should be used at any given phase of the disease process. The respiratory therapist can contribute to the multidisciplinary care plan of the patient with cystic fibrosis to promote the best lung health as well as quality of life. This presentation will detail the pathophysiology of cystic fibrosis as well as the various diagnostic tools and current treatment strategies.

This Live AARC webcast is approved for 1.0 CRCE

This activity has been funded through educational grants from Chiesi and Vertex Pharmaceuticals.

Respiratory Care in Pulmonary Hypertension

Timezone Time
Eastern 2:00 PM
Central 1:00 PM
Mountain 12:00 PM
Pacific 11:00 AM
Universal 7:00 PM
Category Clinical Practice Speaker Robert Walter, MD, MPH, FCCP Date Jun 12, 2018 1:00 PM

Using a case-based approach, the lecture will review the five World Health Organization (WHO) groups of pulmonary hypertension, explaining the different underlying pathogenic mechanisms resulting in each group.  The session will identify treatment approaches to each group, especially WHO group 1/pulmonary arterial hypertension.  Throughout the lecture, there will be emphasis on the role of the Respiratory Therapist in the diagnosis and management of the patient.

This Live AARC webcast is approved for 1.0 CRCE

Childhood Asthma, Attendance and Action Plans

Timezone Time
Eastern 2:00 PM
Central 1:00 PM
Mountain 12:00 PM
Pacific 11:00 AM
Universal 7:00 PM
Category Neonatal-Pediatric Speaker De De Gardner, DrPH, RRT, RRT-NPS, FAARC Date Jun 27, 2018 1:00 PM

According to the Centers for Disease Control and Prevention, asthma is one of the leading causes of school absenteeism in the United States. The respiratory therapist has a unique role in not only the diagnosis and treatment of asthma but also in helping patients and families develop good asthma self-management skills to prevent the negative impact of asthma, including school absenteeism. This presentation will discuss asthma and its impact on student absenteeism, the role of the AAP as a surveillance tool in school districts and the importance of students with asthma having an AAP on record.

This Live AARC webcast is approved for 1.0 CRCE

Alpha-1 Antitrypsin Deficiency and the Respiratory Therapist: Test, Teach, and “Treat”

Timezone Time
Eastern 2:00 PM
Central 1:00 PM
Mountain 12:00 PM
Pacific 11:00 AM
Universal 7:00 PM
Category Clinical Practice Speaker Robert Sandhaus MD, PhD, FCCP Date Jul 10, 2018 1:00 PM

Alpha-1 Antitrypsin Deficiency is a genetic disorder that can result in serious lung disease. This not-so-rare genetic disease is greatly underdiagnosed and is the most common known genetic risk factor for emphysema. Up to 3% of all people diagnosed with COPD may have undetected Alpha-1 Antitrypsin Deficiency. This presentation will provide the respiratory therapist with an appreciation of the disease, its prevalence, and its role in COPD as well as strategies for the respiratory therapist to assist in detection, education, and treatment of this population.

This Live AARC webcast is approved for 1.0 CRCE